Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2025 919.37M
September 30, 2024 680.96M
September 30, 2023 403.63M
September 30, 2022 376.40M
September 30, 2021 367.79M
September 30, 2020 315.49M
September 30, 2019 258.70M
September 30, 2018 76.53M
September 30, 2017 65.61M
September 30, 2016 85.37M
September 30, 2015 98.75M
September 30, 2014 154.16M
September 30, 2013 28.14M
September 30, 2012 3.484M
Date Value
September 30, 2011 8.142M
September 30, 2010 6.847M
September 30, 2009 2.020M
September 30, 2008 10.09M
September 30, 2007 24.12M
September 30, 2006 28.02M
September 30, 2005 22.54M
September 30, 2004 9.041M
September 30, 2003 1.355M
September 30, 2002 0.0185M
September 30, 2001 0.0003M
September 30, 2000 0.002M
September 30, 1999 0.0001M
September 30, 1998 0.001M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 939.65M
Revolution Medicines, Inc. 2.026B
Moderna, Inc. 5.80B
Intellia Therapeutics, Inc. 449.88M
Denali Therapeutics, Inc. 867.88M